Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

New approach for better vision with a retina implant

"In the case of retenitis pigmentosa and also in the case of macular degeneration, the retina chip can help because the remaining nerve tissue is largely intact in the eye, and can be artificially stimulated on the basis of electrostimulation“, explained Frank Rattay of the Institute of Analysis and Scientific Computing at the Vienna University of Technology. In the case of such implants, microchips are implanted in the retina. They convert light signals into electrical pulses which then stimulate the cells of the retina.

The results of the computer simulation of the Viennese researchers published in the scientific journal "Vision Research" were supported by experimental findings by colleagues from Harvard Medical School (USA) and the University Hospital Tübingen in Germany.

Service: http://dx.doi.org/10.1016/j.visres.2014.12.002

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts